These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28280620)

  • 1. Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis.
    Borazanci E; Millis SZ; Kimbrough J; Doll N; Von Hoff D; Ramanathan RK
    J Gastrointest Oncol; 2017 Feb; 8(1):164-172. PubMed ID: 28280620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy.
    Gleeson EM; Feldman R; Mapow BL; Mackovick LT; Ward KM; Morano WF; Rubin RR; Bowne WB
    Am J Clin Oncol; 2018 Aug; 41(8):777-783. PubMed ID: 28263231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites.
    El-Deiry WS; Vijayvergia N; Xiu J; Scicchitano A; Lim B; Yee NS; Harvey HA; Gatalica Z; Reddy S
    Cancer Biol Ther; 2015; 16(12):1726-37. PubMed ID: 26553611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.
    Liu X; Mody K; de Abreu FB; Pipas JM; Peterson JD; Gallagher TL; Suriawinata AA; Ripple GH; Hourdequin KC; Smith KD; Barth RJ; Colacchio TA; Tsapakos MJ; Zaki BI; Gardner TB; Gordon SR; Amos CI; Wells WA; Tsongalis GJ
    Clin Chem; 2014 Jul; 60(7):1004-11. PubMed ID: 24821835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer.
    Tokunaga R; Xiu J; Johnston C; Goldberg RM; Philip PA; Seeber A; Naseem M; Lo JH; Arai H; Battaglin F; Puccini A; Berger MD; Soni S; Zhang W; Hwang JJ; Shields AF; Marshall JL; Baba H; Korn WM; Lenz HJ
    Clin Cancer Res; 2019 May; 25(10):3096-3103. PubMed ID: 30692096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor profiling of gastric and esophageal carcinoma reveal different treatment options.
    Miura JT; Xiu J; Thomas J; George B; Carron BR; Tsai S; Johnston FM; Turaga KK; Gamblin TC
    Cancer Biol Ther; 2015; 16(5):764-9. PubMed ID: 25778705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of molecular targets in vulvar cancers.
    Palisoul ML; Mullen MM; Feldman R; Thaker PH
    Gynecol Oncol; 2017 Aug; 146(2):305-313. PubMed ID: 28536037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemistry features and molecular pathology of appendiceal neoplasms.
    Mikaeel RR; Young JP; Tapia Rico G; Hewett PJ; Hardingham JE; Uylaki W; Horsnell M; Price TJ
    Crit Rev Clin Lab Sci; 2021 Sep; 58(6):369-384. PubMed ID: 33569997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry.
    Nummela P; Saarinen L; Thiel A; Järvinen P; Lehtonen R; Lepistö A; Järvinen H; Aaltonen LA; Hautaniemi S; Ristimäki A
    Int J Cancer; 2015 Mar; 136(5):E282-9. PubMed ID: 25274248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendix.
    Jesinghaus M; Konukiewitz B; Foersch S; Stenzinger A; Steiger K; Muckenhuber A; Groß C; Mollenhauer M; Roth W; Detlefsen S; Weichert W; Klöppel G; Pfarr N; Schlitter AM
    Mod Pathol; 2018 May; 31(5):829-839. PubMed ID: 29327707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.
    Zhu X; Salhab M; Tomaszewicz K; Meng X; Mathew C; Bathini V; Switzer B; Walter O; Cosar EF; Wang X; Lambert LA; Hutchinson LM
    Hum Pathol; 2019 Mar; 85():260-269. PubMed ID: 30458197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Landscape of Appendiceal Neoplasms.
    Ang CS; Shen JP; Hardy-Abeloos CJ; Huang JK; Ross JS; Miller VA; Jacobs MT; Chen IL; Xu D; Ali SM; Baumgartner J; Lowy A; Fanta P; Ideker T; Millis SZ; Harismendy O
    JCO Precis Oncol; 2018; 2():. PubMed ID: 32913983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Characterization of Appendiceal Goblet Cell Carcinoid.
    Arai H; Baca Y; Battaglin F; Kawanishi N; Wang J; Soni S; Zhang W; Millstein J; Johnston C; Goldberg RM; Philip PA; Seeber A; Xiu J; Hwang JJ; Shields AF; Marshall JL; Korn WM; Lenz HJ
    Mol Cancer Ther; 2020 Dec; 19(12):2634-2640. PubMed ID: 33037134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials.
    Meagher NS; Schuster K; Voss A; Budden T; Pang CNI; deFazio A; Ramus SJ; Friedlander ML
    Gynecol Oncol; 2018 Sep; 150(3):527-533. PubMed ID: 30054102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential therapeutic targets by molecular profiling of 628 cases of uterine serous carcinoma.
    Jones NL; Xiu J; Reddy SK; Burke WM; Tergas AI; Wright JD; Hou JY
    Gynecol Oncol; 2015 Sep; 138(3):620-6. PubMed ID: 26123645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetic analysis of appendiceal mucinous adenomas in identical twins, including one with pseudomyxoma peritonei.
    Shih IM; Yan H; Speyrer D; Shmookler BM; Sugarbaker PH; Ronnett BM
    Am J Surg Pathol; 2001 Aug; 25(8):1095-9. PubMed ID: 11474297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic profile of appendiceal goblet cell carcinoid is distinct compared to appendiceal neuroendocrine tumor and conventional adenocarcinoma.
    Wen KW; Grenert JP; Joseph NM; Shafizadeh N; Huang A; Hosseini M; Kakar S
    Hum Pathol; 2018 Jul; 77():166-174. PubMed ID: 29634977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.
    Topcagic J; Feldman R; Ghazalpour A; Swensen J; Gatalica Z; Vranic S
    PLoS One; 2018; 13(1):e0191244. PubMed ID: 29324814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options.
    Ang C; Miura JT; Gamblin TC; He R; Xiu J; Millis SZ; Gatalica Z; Reddy SK; Yee NS; Abou-Alfa GK
    J Surg Oncol; 2016 Jan; 113(1):55-61. PubMed ID: 26661118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
    Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
    Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.